Canada Life’s Madrigal Pharmaceuticals MDGL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $845K | Hold |
1,608
| – | – | ﹤0.01% | 1400 |
|
|
2025
Q4 | $937K | Hold |
1,608
| – | – | ﹤0.01% | 1400 |
|
|
2025
Q3 | $711K | Hold |
1,608
| – | – | ﹤0.01% | 1529 |
|
|
2025
Q2 | $487K | Sell |
1,608
-1,605
| -50% | -$478K | ﹤0.01% | 1609 |
|
|
2025
Q1 | $1.07M | Buy |
3,213
+879
| +38% | +$289K | ﹤0.01% | 1415 |
|
|
2024
Q4 | $719K | Buy |
2,334
+1,045
| +81% | +$294K | ﹤0.01% | 1553 |
|
|
2024
Q3 | $274K | Hold |
1,289
| – | – | ﹤0.01% | 1763 |
|
|
2024
Q2 | $361K | Buy |
1,289
+307
| +31% | +$73.1K | ﹤0.01% | 1747 |
|
|
2024
Q1 | $262K | Hold |
982
| – | – | ﹤0.01% | 1792 |
|
|
2023
Q4 | $226K | Sell |
982
-221
| -18% | -$38.7K | ﹤0.01% | 1826 |
|
|
2023
Q3 | $175K | Buy |
1,203
+700
| +139% | +$132K | ﹤0.01% | 1881 |
|
|
2023
Q2 | $117K | Sell |
503
-63
| -11% | -$17.1K | ﹤0.01% | 1902 |
|
|
2023
Q1 | $137K | Buy |
566
+23
| +4% | +$6.27K | ﹤0.01% | 1929 |
|
|
2022
Q4 | $158K | Hold |
543
| – | – | ﹤0.01% | 1917 |
|
|
2022
Q3 | $35K | Hold |
543
| – | – | ﹤0.01% | 2164 |
|
|
2022
Q2 | $39K | Hold |
543
| – | – | ﹤0.01% | 2105 |
|
|
2022
Q1 | $57K | Hold |
543
| – | – | ﹤0.01% | 2124 |
|
|
2021
Q4 | $46K | Hold |
543
| – | – | ﹤0.01% | 2195 |
|
|
2021
Q3 | $44K | Hold |
543
| – | – | ﹤0.01% | 2267 |
|
|
2021
Q2 | $53K | Sell |
543
-266
| -33% | -$31.5K | ﹤0.01% | 2253 |
|
|
2021
Q1 | $93K | Hold |
809
| – | – | ﹤0.01% | 2119 |
|
|
2020
Q4 | $90K | Hold |
809
| – | – | ﹤0.01% | 2138 |
|
|
2020
Q3 | $96K | Hold |
809
| – | – | ﹤0.01% | 2048 |
|
|
2020
Q2 | $91K | Buy |
809
+286
| +55% | +$28.1K | ﹤0.01% | 2063 |
|
|
2020
Q1 | $35K | Hold |
523
| – | – | ﹤0.01% | 2237 |
|
|
2019
Q4 | $47K | Buy |
+523
| New | +$50.7K | ﹤0.01% | 2282 |
|
|
2019
Q3 | – | Sell |
-985
| Closed | -$103K | – | 1784 |
|
|
2019
Q2 | $103K | Hold |
985
| – | – | ﹤0.01% | 2219 |
|
|
2019
Q1 | $123K | Hold |
985
| – | – | ﹤0.01% | 2001 |
|
|
2018
Q4 | $107K | Buy |
985
+366
| +59% | +$56.6K | ﹤0.01% | 2127 |
|
|
2018
Q3 | $133K | Hold |
619
| – | – | ﹤0.01% | 2102 |
|
|
2018
Q2 | $173K | Hold |
619
| – | – | ﹤0.01% | 2018 |
|
|
2018
Q1 | $72K | Hold |
619
| – | – | ﹤0.01% | 2272 |
|
|
2017
Q4 | $57K | Buy |
+619
| New | +$35.4K | ﹤0.01% | 2328 |
|
|
2015
Q3 | – | Sell |
-241
| Closed | -$20K | – | 2520 |
|
|
2015
Q2 | $20K | Buy |
+241
| New | +$20.2K | ﹤0.01% | 2464 |
|
Other funds holding MDGL
BBA
RI
ACA
PC
VPM
VCM
Canada Life's MDGL Position: Q1 2026 in Review
Canada Life held its Madrigal Pharmaceuticals (MDGL) position steady in Q1 2026 at 1,608 shares worth $845K. The position accounts for ﹤0.01% of the portfolio, ranked #1400.
Canada Life first reported a position in MDGL in Q2 2015 and has held it in 34 quarters since. The position peaked at $1.07M in Q1 2025. 378 funds tracked by Wall St. Rank hold MDGL as of Q1 2026.
- Canada Life held 1,608 shares of Madrigal Pharmaceuticals worth $845K as of Q1 2026.
- Canada Life left its Madrigal Pharmaceuticals share count unchanged in Q1 2026.
- Madrigal Pharmaceuticals made up ﹤0.01% of Canada Life's portfolio in Q1 2026, its #1400 holding.
- Canada Life first reported a position in Madrigal Pharmaceuticals in Q2 2015 and has held it in 34 quarters since.
- Canada Life's Madrigal Pharmaceuticals position peaked at $1.07M in Q1 2025.
- 378 funds tracked by Wall St. Rank held Madrigal Pharmaceuticals as of Q1 2026.
Based on Canada Life's 13F filing for Q1 2026, filed 14 May 2026.